Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel nickel-catalyzed method for ketone nitrile compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing significantly
Patent CN111423381B reveals a mild palladium-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified operations for API manufacturing.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Patent CN115286628B details palladium catalyzed carbonylation for high purity intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation method for benzofuran-3-carboxamide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation avoids toxic CO gas. Offers cost reduction and scalable supply chain solutions for high-purity pharmaceutical intermediates manufacturing.
Novel CuCl-catalyzed route for 1,2,4-triazolyl arylamines. Cost-effective, scalable, no anhydrous conditions. Ideal for API intermediates.
Patent CN115260188A details a novel cobalt-catalyzed C-H activation method for tetrahydro-beta-carbolinones, offering cost reduction in API manufacturing and scalable production.
Patent CN117447451A details a novel palladium-catalyzed synthesis avoiding toxic gas. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method offers high yield and scalability for trifluoromethyl imidazole production, significantly reducing operational costs for global API manufacturers.
Patent CN115260080B reveals efficient Pd-catalyzed carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed carbonylation method offers high purity and scalable production for pharmaceutical intermediates supply chain optimization and cost reduction.
Novel Pd-catalyzed route using benzisoxazole offers high yields and broad functional group tolerance for scalable pharmaceutical intermediate production.
Patent CN115353511A details a safe, multi-component synthesis of trifluoromethyl-biheterocycles using palladium catalysis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111423381A details a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering cost reduction in API manufacturing and scalable production capabilities.
Patent CN115260188B reveals cobalt-catalyzed carbonylation. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel atmospheric palladium catalysis reduces cost and complexity in manufacturing high-purity pharmaceutical intermediates for global supply chains.
Novel cobalt-catalyzed carbonylation patent offers cost-effective, scalable production of high-purity pharmaceutical intermediates with simplified supply chains.